Bioextrax AB

Bioextrax AB

Bioextrax AB

Date Founded



Ideongatan 3A, Lund, 223 62, SWE

Type of Company


Employees (Worldwide)

1 - 10


IT Consulting & Services

Company Description

Bioextrax AB engages in the development and commercialization of bio-extraction platform technology. It develops, tests, and verifies a potent microbial strain that can extract a variety of pure polyhydroxyalkanoates (PHA) bio-plastic granules from different PHA producing bacteria. Its technology is based on the selective lysis of microbial cell walls under mild conditions using a novel proprietary microbial isolate. The company was founded by Mohammad Hamed Ahmad Ibrahim and Rajni Hatti-Kaul on February 6, 2014 and is headquartered in Lund, Sweden.

Executives & Employees
Paths to Bioextrax AB
Potential Connections via
Relationship Science
Bioextrax AB
Recent Transactions
Details Hidden

Bioextrax AB issued SEK Ordinary Shares

Transaction Advisors

Advised onBioextrax AB issued SEK Ordinary Shares

Key Stats and Financials As of 2020
Market Capitalization
Total Enterprise Value
Earnings Per Share
Debt TEV
TEVNet Income
Enterprise Value / Sales
Net Profit
Total Equity
Total Debt
Details Hidden

Head-Department of Biotechnology at Lund University

Details Hidden

LU Holding's investment strategy focuses on innovations and projects needing start-up, early-stage or early expansion capital. Their investment objective has a stringent commercial focus. Their goal is to create value growth for the inventors, Lund University, the investors and society. Their primary geographic focus is Sweden.The firm is an active investment partner which has invested in projects and spin-out firms active in areas such as supervisory and control applications that optimize the production of biogas, mobile communications and intelligent surveillance, Web-based platform for distance learning, computer assisted diagnostic software for nuclear medicine, medical devices for colorectal surgery, algorithms for faster graphics hardware, antibody drug projects within the areas of thrombosis, cancer, atherosclerosis and ophthalmic diseases, peptide therapeutics, analytical separation techniques, and proteomic research for mass spectrometry analysis.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Bioextrax AB. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Bioextrax AB's profile does not indicate a business or promotional relationship of any kind between RelSci and Bioextrax AB.